4.8 Article

Using Two Peptide Isotopologues as Internal Standards for the Streamlined Quantification of Low-Abundance Proteins by Immuno-MRM and Immuno-MALDI

期刊

ANALYTICAL CHEMISTRY
卷 92, 期 18, 页码 12407-12414

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.0c02157

关键词

-

资金

  1. Genome Canada [GTP: 264PRO]
  2. Genome British Columbia [GTP: 264PRO]
  3. Genome British Columbia
  4. Genome Quebec through the Genomics Applications Partnership Program (GAPP) [183AKT, PD-L1]
  5. Terry Fox Research Institute
  6. Leading Edge Endowment Fund (University of Victoria)
  7. Segal McGill Chair in Molecular Oncology at McGill University (Montreal, Quebec, Canada)
  8. Warren Y. Soper Charitable Trust
  9. Alvin Segal Family Foundation
  10. Partnership for Clean Competition (PCC
  11. Colorado Springs, CO, USA)
  12. MegaGrant of the Ministry of Science and Higher Education of the Russian Federation
  13. Skolkovo Institute of Science and Technology [075-10-2019-083]

向作者/读者索取更多资源

Mass spectrometry (MS), particularly targeted proteomics, is increasingly being used for quantifying specific proteins and peptides in clinical specimens. The coupling of immuno-enrichment of proteotypic peptides with MS [e.g., immuno-multiple reaction monitoring (MRM) and immuno-matrix-assisted laser desorption ionization (MALDI)] enables the development of highly sensitive and specific assays for low-abundance signaling proteins. By incorporating stable isotopelabeled standards, these workflows allow the determination of endogenous protein concentrations. This is typically achieved through external calibration, often using surrogate matrices, which has inherent limitations for the analysis of clinical specimens as there are often substantial variations in the sample matrix, and sample amounts are typically limited. We have previously introduced the use of two peptide isotopologues for generating external calibration curves in plasma. Here, we present a two-point internal calibration (2-PIC) strategy using two isotopologues for immuno-MS assays and demonstrate its flexibility and robustness. Quantification of the tumor suppressor PTEN in Colo-205 cells by immuno-MRM and immuno-MALDI using 2-PIC and external calibration yielded very similar results (relative standard deviation between 2-PIC and external calibration: 4.9% for immuno-MRM; 1.1% for immuno-MALDI), without the need for a surrogate matrix or additional patient material for calibration, while concurrently reducing the instrument time and cost. Although our PTEN immuno-MRM and immuno-MALDI assays can be considered to be orthogonal as they utilized entirely different sample preparation and MS analysis workflows, targeted different PTEN peptides, and were performed in different laboratories, the endogenous Colo-205 PTEN levels determined with 2-PIC showed a good correlation (r(2) = 0.9966) and good agreement (0.48 +/- 0.01 and 0.29 +/- 0.02 mu mol/mu g of total protein) between immuno-MRM and immuno-MALDI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据